CSPC Innovation Pharmaceutical Co., Ltd. (300765.SZ)
CNY 27.6
(-0.11%)
CNY 27.6
(-0.11%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 927.24 Million | 640.71 Million | 170.59 Million | 349.07 Million | 315.38 Million | 159.72 Million |
| Net Income | 755.55 Million | 726.61 Million | 316.54 Million | 299.71 Million | 273.52 Million | 224.32 Million |
| Depreciation & Amortization | 100.09 Million | 72.94 Million | 51.37 Million | 53.41 Million | 47.13 Million | 43.03 Million |
| Deferred income taxes | 1.47 Million | -6.98 Million | -1 Million | 2.29 Million | -682.71 Thousand | -3.91 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 111.1 Million | -99.45 Million | -200.18 Million | 22.15 Million | 13.62 Million | -103.15 Million |
| Other non-cash items | 48.1 Million | -59.38 Million | 2.85 Million | -26.21 Million | -18.91 Million | -4.46 Million |
| Investing Cash Flow | -92.98 Million | 311.87 Million | -26.85 Million | 346.16 Million | -1.07 Billion | -45.99 Million |
| Investments in PPE | -95.73 Million | -114.05 Million | -66.91 Million | -117.74 Million | -106.09 Million | -58.96 Million |
| Acquisitions | 3.74 Million | 5.81 Million | 118.79 Million | 120.57 Million | 106.52 Million | 48.83 Thousand |
| Investment purchases | -1 Million | -910 Million | -1.36 Billion | -2.49 Billion | -2.42 Billion | -10 Million |
| Sales/Maturities of investments | -2.74 Million | 1.33 Billion | 1.27 Billion | 2.95 Billion | 1.45 Billion | 10.11 Million |
| Other Investing Activities | 2.74 Million | -0.36 | 2.29 Million | -117.74 Million | -106.09 Million | 12.81 Million |
| Financing Cash Flow | 365.2 Million | -63 Million | -42.86 Million | -28 Million | 1.07 Billion | -28.22 Million |
| Debt repayment | -20 Million | -20 Million | -863.94 Thousand | - | -70.15 Million | -43.93 Million |
| Dividends payments | -97.56 Million | -97.56 Million | -42 Million | -28 Million | -1.49 Million | -3.39 Million |
| Common Stock Repurchased | -4.24 Million | -68.79 Thousand | - | - | - | - |
| Common Stock Issuance | 488.16 Million | - | - | - | - | - |
| Other Financing Activities | -1.15 Million | 39.06 Million | -863.94 Thousand | - | 1.14 Billion | 19.1 Million |
| Accounts receivables | 165.85 Million | -224.89 Million | -119.2 Million | 38.9 Million | -15.67 Million | -138.26 Million |
| Accounts payables | -58.65 Million | 157.24 Million | 56.7 Million | -32.27 Million | 24.77 Million | 54.62 Million |
| Inventory | 3.9 Million | -24.81 Million | -105.85 Million | 13.23 Million | 5.2 Million | -15.59 Million |
| Other working capital | -57.17 Million | -6.98 Million | -31.82 Million | 2.29 Million | -682.71 Thousand | -87.55 Million |
| Cash at beginning of period | 2.19 Billion | 1.24 Billion | 1.13 Billion | 472.63 Million | 153.89 Million | 68.22 Million |
| Cash at end of period | 3.42 Billion | 2.19 Billion | 1.23 Billion | 1.13 Billion | 472.63 Million | 153.89 Million |
| Capital Expenditure | -95.73 Million | -114.05 Million | -66.91 Million | -117.74 Million | -106.09 Million | -58.96 Million |
| Effect of forex changes on cash | 31.16 Million | 57.54 Million | -6.75 Million | -2.12 Million | 2.26 Million | 159.95 Thousand |
| Net cash flow / Change in cash | 1.22 Billion | 947.13 Million | 94.11 Million | 665.1 Million | 318.73 Million | 85.67 Million |
| Free Cash Flow | 831.5 Million | 526.66 Million | 103.67 Million | 231.32 Million | 209.28 Million | 100.76 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.3 Million | 57.96 Million | 79.06 Million | 755.55 Million | 172.08 Million | 182.85 Million |
| Depreciation & Amortization | - | 52.5 Million | 52.5 Million | 100.09 Million | 25.21 Million | 25.21 Million |
| Deferred income taxes | - | - | - | 1.47 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -126.91 Million | - | 111.1 Million | 169.75 Million | -5.17 Million |
| Other non-cash items | -16.43 Million | 28.46 Million | -1.05 Billion | 48.1 Million | -116.75 Million | 127.68 Million |
| Investing Cash Flow | -157.77 Million | -687.28 Million | -73.8 Million | -92.98 Million | -4.78 Million | -41.14 Million |
| Investments in PPE | -222.47 Million | -190.68 Million | -73.8 Million | -95.73 Million | -6.18 Million | -41.3 Million |
| Acquisitions | 580.01 Thousand | 3.39 Million | - | 3.74 Million | 2.39 Million | 154.85 Thousand |
| Investment purchases | -35.88 Million | -500 Million | - | -1 Million | -1 Million | - |
| Sales/Maturities of investments | 100 Million | - | - | -2.74 Million | -1.39 Million | - |
| Other Investing Activities | 100.58 Million | -496.6 Million | - | 2.74 Million | 1.39 Million | 0.82 |
| Financing Cash Flow | -9.8 Million | -561.49 Million | -35.83 Million | 365.2 Million | -4.4 Million | -20.26 Million |
| Debt repayment | - | - | - | -20 Million | -22.49 Thousand | -20.12 Million |
| Dividends payments | -374.16 Million | -374.16 Million | - | -97.56 Million | -97.56 Million | -124.76 Thousand |
| Common Stock Repurchased | 222.74 Million | -222.74 Million | - | -4.24 Million | -4.24 Million | -511.48 Thousand |
| Common Stock Issuance | - | - | - | 488.16 Million | 488.16 Million | 511.48 Thousand |
| Other Financing Activities | -9.8 Million | -338.32 Million | -35.83 Million | -1.15 Million | -390.74 Million | -12.2 Thousand |
| Accounts receivables | - | -50.83 Million | - | 165.85 Million | 165.85 Million | 7.59 Million |
| Accounts payables | - | - | - | -58.65 Million | - | - |
| Inventory | - | -76.07 Million | - | 3.9 Million | 3.9 Million | -12.77 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.47 Billion | 2.68 Billion | 3.77 Billion | 2.19 Billion | 3.16 Billion | 2.89 Billion |
| Cash at end of period | 1.28 Billion | 1.48 Billion | 2.68 Billion | 3.42 Billion | 3.42 Billion | 3.15 Billion |
| Capital Expenditure | -222.47 Million | -190.68 Million | -73.8 Million | -95.73 Million | -6.18 Million | -41.3 Million |
| Effect of forex changes on cash | -6.52 Million | 4.05 Million | 1.11 Million | 31.16 Million | 22.19 Million | -7.3 Million |
| Net cash flow / Change in cash | -188.23 Million | -1.2 Billion | -1.08 Billion | 1.22 Billion | 255.89 Million | 261.86 Million |
| Free Cash Flow | -236.6 Million | -156.76 Million | -1.04 Billion | 831.5 Million | 244.11 Million | 289.27 Million |
LTMCF
RPMT
ADCINDIA
MDJH
LADX
LUVE